Starting from the fact that minorities account for fewer than 10 percent of patients enrolled in clinical trials.  Health disparities and underrepresentation in clinical trials could become a serious issue in the upcoming years.  FDA Regulations In 2012 Congress included Section … Continue reading 6 Reasons to Diversify Clinical Trials